New Key Statistics Module, Z-Score and F-Score
SZSE:301075 Key Ratios
Market Cap ¥ M | 1,288.80 |
Enterprise Value ¥ M | 1,050.59 |
P/E(ttm) | 67.13 |
PE Ratio without NRI | 66.30 |
Forward PE Ratio | -- |
Price/Book | 1.72 |
Price/Sales | 3.81 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 334.00 |
EPS (TTM) ¥ | 0.24 |
Beneish M-Score | -2.05 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -42.00 |
y-y EBITDA Growth Rate % | 126.60 |
EV-to-EBIT | 42.41 |
EV-to-EBITDA | 42.41 |
PEG | -- |
Shares Outstanding M | 80.00 |
Net Margin (%) | 5.60 |
Operating Margin % | 3.21 |
Pre-tax Margin (%) | 6.30 |
Quick Ratio | 5.18 |
Current Ratio | 5.43 |
ROA % (ttm) | 1.82 |
ROE % (ttm) | 2.44 |
ROIC % (ttm) | 1.60 |
Dividend Yield % | 0.78 |
Altman Z-Score | 3.61 |
SZSE:301075 Number of Guru Trades
SZSE:301075 Volume of Guru Trades
Gurus Latest Trades with SZSE:301075
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:301075 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Tibet Duo Rui Pharmaceutical Co Ltd Insider Transactions
No Available Data